Obesity Drug Use Surges, Surgery Declines

This is a news story, published by Harvard Gazette, that relates primarily to Ozempic news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Harvard Gazette news

For more news from Harvard Gazette, you can click here:

more news from Harvard Gazette

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

bariatric metabolic surgery

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity treatment news, bariatric surgery programs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

effective obesity treatment

Harvard Gazette

•

Weight-loss surgery down 25% as anti-obesity drug use soars — Harvard Gazette

Summary

Nutrition label

89% Informative

A new study examining a large sample of privately insured patients with obesity found that use of drugs such as Ozempic and Wegovy as anti-obesity medications more than doubled from 2022 to 2023 .

During that same period, there was a 25.6 percent decrease in patients undergoing metabolic bariatric surgery to treat obesity.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech